SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
McLerran, Dale
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. [electronic resource] - Clinical chemistry Jan 2008 - 53-60 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
0009-9147
10.1373/clinchem.2007.091496 doi
Adenocarcinoma--diagnosis
Aged
Aged, 80 and over
Bias
Biomarkers, Tumor--blood
Blood Specimen Collection
Case-Control Studies
Humans
Male
Middle Aged
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--diagnosis
Proteomics
Retrospective Studies
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. [electronic resource] - Clinical chemistry Jan 2008 - 53-60 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
0009-9147
10.1373/clinchem.2007.091496 doi
Adenocarcinoma--diagnosis
Aged
Aged, 80 and over
Bias
Biomarkers, Tumor--blood
Blood Specimen Collection
Case-Control Studies
Humans
Male
Middle Aged
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--diagnosis
Proteomics
Retrospective Studies
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization